Filing: 0001012975-26-000155
Total Filing Value
$5.61BIssuer | Symbol | Class | CUSIP | Value | Shares | Put/Call |
|---|---|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | $588,296,914 | 1,995,986 | — | |
| CELCUITY INC | CELC | COM | 15102K100 | $315,198,348 | 3,160,200 | — |
| RHYTHM PHARMACEUTICALS INC | RYTM | COM | 76243J105 | $272,565,693 | 2,546,391 | — |
| ASCENDIS PHARMA A/S | ASND | SPONSORED ADR | 04351P101 | $230,602,214 | 1,081,421 | — |
| APOGEE THERAPEUTICS INC | COM | 03770N101 | $175,917,537 | 2,330,651 | — | |
| ROIVANT SCIENCES LTD | SHS | G76279101 | $173,284,504 | 7,985,461 | — | |
| NUVALENT INC | COM | 670703107 | $167,492,912 | 1,665,105 | — | |
| TRAVERE THERAPEUTICS INC | COM | 89422G107 | $163,469,258 | 4,278,180 | — | |
| SPDR SERIES TRUST | STATE STREET SPD | 78464A870 | $134,123,000 | 1,100,000 | Put | |
| EXACT SCIENCES CORP | EXAS | COM | 30063P105 | $121,921,460 | 1,200,487 | — |
| PROTAGONIST THERAPEUTICS INC | PTGX | COM | 74366E102 | $117,946,120 | 1,350,425 | — |
| INHIBRX BIOSCIENCES INC | COM | 45720N103 | $114,763,853 | 1,452,707 | — | |
| EDGEWISE THERAPEUTICS | EWTX | COM | 28036F105 | $110,624,625 | 4,457,974 | — |
| IMMATICS N.V | IMTX | SHS | N44445109 | $109,026,288 | 10,383,456 | — |
| SPYRE THERAPEUTICS INC | SYRE | COM NEW | 00773J202 | $100,547,811 | 3,069,225 | — |
| AMYLYX PHARMACEUTICALS INC | AMLX | COM | 03237H101 | $100,081,375 | 8,284,882 | — |
| ARCELLX INC | ACLX | COMMON STOCK | 03940C100 | $95,587,829 | 1,466,071 | — |
| VIRIDIAN THERAPEUTICS INC | VRDN | COM | 92790C104 | $94,688,917 | 3,042,703 | — |
| BOSTON SCIENTIFIC CORP | BSX | COM | 101137107 | $93,347,650 | 979,000 | — |
| AMICUS THERAPEUTICS INC | FOLD | COM | 03152W109 | $90,720,918 | 6,370,851 | — |
Rows:
1–20 of 116